Caspase-8 activation by TRAIL monotherapy predicts responses to IAPi and TRAIL combination treatment in breast cancer cell linesRadosław Polański(AstraZeneca (United Kingdom)), Eric Tang(AstraZeneca (United Kingdom))Cell Death and DiseaseOctober 1, 201510.1038/cddis.2015.234Cited by 25SaveCiteExport RISWatch citationsRelated PapersCombined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy|British Journal of Urology|2011|35